These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 28643248)

  • 1. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
    Wang Q; Ui-Tei K
    Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites.
    Naito Y; Hino K; Bono H; Ui-Tei K
    Bioinformatics; 2015 Apr; 31(7):1120-3. PubMed ID: 25414360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.
    Hay EA; Khalaf AR; Marini P; Brown A; Heath K; Sheppard D; MacKenzie A
    Neuropeptides; 2017 Aug; 64():101-107. PubMed ID: 27866656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Off-Spotter": very fast and exhaustive enumeration of genomic lookalikes for designing CRISPR/Cas guide RNAs.
    Pliatsika V; Rigoutsos I
    Biol Direct; 2015 Jan; 10():4. PubMed ID: 25630343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OffScan: a universal and fast CRISPR off-target sites detection tool.
    Cui Y; Liao X; Peng S; Tang T; Huang C; Yang C
    BMC Genomics; 2020 Mar; 21(Suppl 1):872. PubMed ID: 32138651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method to convert mRNA into a gRNA library for CRISPR/Cas9 editing of any organism.
    Arakawa H
    Sci Adv; 2016 Aug; 2(8):e1600699. PubMed ID: 27574704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
    Fu Y; Reyon D; Joung JK
    Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
    Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
    Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploiting off-targeting in guide-RNAs for CRISPR systems for simultaneous editing of multiple genes.
    Ferreira R; Gatto F; Nielsen J
    FEBS Lett; 2017 Oct; 591(20):3288-3295. PubMed ID: 28884816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating Heritable Mutations in Drosophila with CRISPR-Cas9.
    Port F; Bullock SL
    Methods Mol Biol; 2016; 1478():145-160. PubMed ID: 27730579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.
    Cram D; Kulkarni M; Buchwaldt M; Rajagopalan N; Bhowmik P; Rozwadowski K; Parkin IAP; Sharpe AG; Kagale S
    BMC Plant Biol; 2019 Nov; 19(1):474. PubMed ID: 31694550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
    Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
    Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR Genome Editing Made Easy Through the CHOPCHOP Website.
    Labun K; Krause M; Torres Cleuren Y; Valen E
    Curr Protoc; 2021 Apr; 1(4):e46. PubMed ID: 33905612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
    Moreb EA; Hutmacher M; Lynch MD
    CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-target assessment of CRISPR-Cas9 guiding RNAs in human iPS and mouse ES cells.
    Tan EP; Li Y; Velasco-Herrera Mdel C; Yusa K; Bradley A
    Genesis; 2015 Feb; 53(2):225-36. PubMed ID: 25378133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.